LNF1901
/ Lunan Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 26, 2024
Phase I Study of LNF1901 in Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=82 | Not yet recruiting | Sponsor: Shandong New Time Pharmaceutical Co., LTD
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1